NCT00491153 Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist Pulmonologist Status TERMINATED Phase N/A
NCT00490243 Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma Status COMPLETED Phase PHASE4
NCT00487773 Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma Status COMPLETED Phase PHASE4
NCT00486343 Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS Status TERMINATED Phase PHASE4
NCT00483899 Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects Status COMPLETED Phase PHASE1
NCT00483041 A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528 Status TERMINATED Phase PHASE2
NCT00482898 A Study of MK0359 in Patients With Chronic Asthma (0359-013) Status COMPLETED Phase PHASE2
NCT00482508 Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients Status COMPLETED Phase PHASE3
NCT00482248 Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma Status COMPLETED Phase PHASE3
NCT00480649 Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) Status COMPLETED Phase PHASE4
NCT00479739 CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. Status COMPLETED Phase PHASE4
NCT00476268 Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma Status COMPLETED Phase PHASE3
NCT00475813 Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma Status COMPLETED Phase PHASE3
NCT00471809 Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS) Status TERMINATED Phase PHASE4
NCT00469989 Randomised Placebo Controlled Study of Effects of Therapeutic Hookworm Infection in Asthma Status COMPLETED Phase NA
NCT00468975 A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients. Status COMPLETED Phase PHASE2
NCT00467740 Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma Status COMPLETED Phase PHASE2